PrognomIQ

San Mateo, CA · Founded 2020 · Privately Held (backing)

Developer of medical test products designed to transform the detection and treatment of cancer and other complex diseases. PrognomIQ is based in San Mateo, CA and was founded in 2020. It is valued at about $316 million as of Oct 2026, set by institutional fund marks. It has raised $172 million across 3 recorded rounds; the latest was an $11.9 million early-stage round in Jan 2026.

PMV mark · valuation
$315.6M
Oct 2026
Priced at
—
Total raised
$171.8M
Last round
Early Stage VC
Jan 2026

Who backs PrognomIQ?

12 investors
InvestorType
Emerson CollectiveOther
Wing Venture CapitalVenture capital
Catalio Capital ManagementVenture capital
T. Rowe Price Group—
Fidelity—
The Invus GroupPE / buyout
Maverick VenturesHedge fund
Bruker—
HBM Genomics—
Seer—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

PrognomIQ investors

12 investors are on record for PrognomIQ, including Emerson Collective, Wing Venture Capital, Catalio Capital Management and T. Rowe Price Group. The early-stage round in Jan 2026 drew 6 investors.

Free account
More of PrognomIQ with a free account
  • ·The complete investor list: 12 names
  • ·Watch PrognomIQ: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like PrognomIQ. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View